000 | 01079 a2200313 4500 | ||
---|---|---|---|
005 | 20250512234722.0 | ||
264 | 0 | _c19830225 | |
008 | 198302s 0 0 eng d | ||
022 | _a0008-5472 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aForssen, E A | |
245 | 0 | 0 |
_aImproved therapeutic benefits of doxorubicin by entrapment in anionic liposomes. _h[electronic resource] |
260 |
_bCancer research _cFeb 1983 |
||
300 |
_a546-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aLiposomes _xadministration & dosage |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNeoplasms, Experimental _xdrug therapy |
650 | 0 | 4 |
_aSarcoma 180 _xdrug therapy |
650 | 0 | 4 |
_aSarcoma, Experimental _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aTökés, Z A | |
773 | 0 |
_tCancer research _gvol. 43 _gno. 2 _gp. 546-50 |
|
999 |
_c6847914 _d6847914 |